NCT06747312: Effect of Belimumab on Antibody Titers in Primary APS Patients
- State
- Under way
- Phase
- Phase 2
- People
- 20 planned
- Started
- 1 Apr 2024
- Primary completion
- 31 May 2026
- Arms
- Experimental: SOC+Belimumab arm
- Results
- None posted
- 1 Apr 2024: Trial started
- 24 Dec 2024: Trial registered